Pharma Equity Group A/S Cl A (PEG) — Cash Flow Quality Index
Pharma Equity Group A/S Cl A (PEG) has a Cash Flow Quality Index of 0.36x as of December 2022. Operating cash flow of Dkr4.24 Million is below net income of Dkr11.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PEG cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharma Equity Group A/S Cl A Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Pharma Equity Group A/S Cl A across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pharma Equity Group A/S Cl A (PEG) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Pharma Equity Group A/S Cl A (2017–2022)
Year-by-year earnings quality comparison for Pharma Equity Group A/S Cl A. For live market cap and the full company financial profile, see how much is Pharma Equity Group A/S Cl A worth.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.83x | Dkr-2.87 Million | Dkr3.48 Million | ▼ -113.2% |
| 2021 | -0.39x | Dkr-2.09 Million | Dkr5.39 Million | ▲ +98.6% |
| 2017 | -27.80x | Dkr-4.92 Million | Dkr177.00K | — |